Low-dose Cytarabine for Acute Myeloid Leukaemia (AML)

Regular price £0.00

Tax included.

What's in this booklet? 

Cytarabine (also called cytosine arabinoside or Ara-C) is a treatment for leukaemia, particularly acute myeloid leukaemia (AML). It can be administered at different doses, generally referred to as ‘high’, ‘intermediate’ and ‘low’. High and intermediate dose cytarabine are generally used as part of the intensive chemotherapy treatment of AML. Low-dose cytarabine generally refers to the doses of cytarabine commonly used in the non-intensive treatment of AML, either alone or in combination with other drugs

This hardcopy version of our booklet can be ordered free of charge to UK addresses. 

Add donation

>